Pricing Log in Create free account

Compass Therapeutics, Inc. (CMPX) vs Innate Pharma S.A. Sponsored ADR (IPHA)

Compass Therapeutics, Inc. and Innate Pharma S.A. Sponsored ADR are both Biotechnology companies. Compass Therapeutics, Inc. and Innate Pharma S.A. Sponsored ADR are of similar size ($165.3M and $161.5M). Compass Therapeutics, Inc. has the higher net margin (0.00% vs −99.7%) and the higher return on invested capital (0.00% vs 0.00%). Across the 9 metrics below, Innate Pharma S.A. Sponsored ADR leads on 6 and Compass Therapeutics, Inc. on 3.

Valuation

Metric CMPX IPHA Biotechnology median
P/E n/m n/m 8.50
P/S n/m n/m 9.71
P/B 0.97 n/m 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA 0.17 n/m 0.64
EV/Sales n/m 0.12 9.21
Earnings yield (46.51%) (81.58%) (33.15%)
Free cash flow yield (35.09%) 0.00% (25.50%)

Profitability

Metric CMPX IPHA Biotechnology median
Gross margin 0.00% 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% (99.70%) 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (56.66%) 0.00% (56.36%)
Return on assets (47.87%) 0.00% (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric CMPX IPHA Biotechnology median
Revenue growth (TTM) — (4.17%) 6.02%
EPS growth (last fiscal year) (16.67%) 6.06% 30.26%
Revenue growth, 5-year CAGR — (33.86%) 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CMPX IPHA Biotechnology median
Debt to equity 0.00 (0.50) 0.00
Current ratio 11.22 0.60 4.72
Net debt to EBITDA 2.86 0.22 0.96

Dividend

Metric CMPX IPHA Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric CMPX IPHA Biotechnology median
Market cap 161.49m 165.32m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack